E-LIB Suche - Ergebnisse für: Åleskog, Anna

1

In vitro evaluation of clinical activity and toxicity of an..:

Haglund, Caroline ; Åleskog, Anna ; Nygren, Peter...
Cancer Chemotherapy and Pharmacology. 69 (2011) 3 - p. 697-707 , 2011

Link: https://doi.org/10.1007/..

2

Lack of association between the MDM2 promoter polymorphism ..:

Kaderi, Mohd Arifin ; Mansouri, Mahmoud ; Zainuddin, Norafiza...
Leukemia Research. 34 (2010) 3 - p. 335-339 , 2010

Link: https://doi.org/10.1016/..

3

Identification of AKN-032, a novel 2-aminopyrazine tyrosine..:

Eriksson, Anna ; Höglund, Martin ; Lindhagen, Elin...
Biochemical Pharmacology. 80 (2010) 10 - p. 1507-1516 , 2010

Link: https://doi.org/10.1016/..

4

IGHV3‐21 gene usage is associated with high TCL1 expression..:

Mansouri, Mahmoud R. ; Sevov, Marie ; Åleskog, Anna...
European Journal of Haematology. 84 (2010) 2 - p. 109-116 , 2010

Link: https://doi.org/10.1111/..

5

The FMCA-GM assays, high throughput non-clonogenic alternat..:

Haglund, Caroline ; Åleskog, Anna ; Håkansson, Lena Douhan...
Toxicology Letters. 194 (2010) 3 - p. 102-107 , 2010

Link: https://doi.org/10.1016/..

6

In vitroactivity of 20 agents in different prognostic subgr..:

Lindhagen, Elin ; Norberg, Maria ; Kanduri, Meena...
European Journal of Haematology. 83 (2009) 1 - p. 22-34 , 2009

Link: https://doi.org/10.1111/..

7

In vitro activity of bortezomib in cultures of patient tumo..:

Wiberg, Kristina ; Carlson, Kristina ; Åleskog, Anna...
Medical Oncology. 26 (2008) 2 - p. 193-201 , 2008

Link: https://doi.org/10.1007/..

8

The GNAS1 T393C polymorphism and lack of clinical prognosti..:

Kaderi, Mohd Arifin ; Murray, Fiona ; Jansson, Mattias...
Leukemia Research. 32 (2008) 6 - p. 984-987 , 2008

Link: https://doi.org/10.1016/..

9

Significant cytotoxic activity in vitro of the EGFR tyrosin..:

Lindhagen, Elin ; Eriksson, Anna ; Wickström, Malin...
European Journal of Haematology. 81 (2008) 5 - p. 344-353 , 2008

Link: https://doi.org/10.1111/..

10

Telomere length and correlation with histopathogenesis in B..:

Walsh, Sarah H. ; Grabowski, Pawel ; Berglund, Mattias...
European Journal of Haematology. 78 (2007) 4 - p. 283-289 , 2007

Link: https://doi.org/10.1111/..

11

Pharmacological profiling of novel non-COX-inhibiting indol..:

Lindhagen, Elin ; Rickardson, Linda ; Elliott, Gary...
Investigational New Drugs. 25 (2007) 4 - p. 297-303 , 2007

Link: https://doi.org/10.1007/..

12

R-etodolac (SDX-101) and the related indole–pyran analogues..:

Lindhagen, Elin ; Nissle, Sara ; Leoni, Lorenzo...
Cancer Chemotherapy and Pharmacology. 60 (2006) 4 - p. 545-553 , 2006

Link: https://doi.org/10.1007/..

13

In vitro activity of the flt3-inhibitor su5614 and standard..:

Åleskog, Anna ; Höglund, Martin ; Pettersson, Jenny...
Leukemia Research. 29 (2005) 9 - p. 1079-1081 , 2005

Link: https://doi.org/10.1016/..

14

VH gene mutation status and cellular drug resistance in chr..:

Åleskog, Anna ; Tobin, Gerard ; Laurell, Anna...
European Journal of Haematology. 73 (2004) 6 - p. 407-411 , 2004

Link: https://doi.org/10.1111/..

15

Single-tube nested quantitative PCR: a rational and sensiti..:

Forsman, Anna ; Uzameckis, Dmitrijs ; Rönnblom, Lars...
Journal of Virological Methods. 111 (2003) 1 - p. 1-11 , 2003

Link: https://doi.org/10.1016/..